Legend Biotech Corp - ADR

NASDAQ:LEGN   3:59:58 PM EDT
40.37
-0.52 (-1.27%)
Other Pre-Announcement

Legend Biotech Reports Q1 Loss Per Share Of $0.30

Published: 05/18/2021 12:17 GMT
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Reports First Quarter 2021 Financial Results and Recent Highlights.
Q1 Loss per Share $0.30.
Q1 Revenue $13.7 Million.
Q1 Earnings per Share Estimate $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Expects to Initiate Its Phase 1 Clinical Trial of Lb1901 in Rr T-cell Lymphoma in United States in 2021.
Anticipates Supporting Investigators With Publishing a Clinical Data Update From Legend-2 Study in 2021.
As of March 31, 2021, Legend Biotech Had About $412.3 Million of Cash and Cash Equivalents.